Anti-smoking policies: parliamentarians' perceptions influenced by the industry and its allies

A recent study published in the journal Tobacco Prevention & Cessation analyzes the perceptions of French parliamentarians regarding tobacco control policies, the stakeholders involved, and the measures deemed priorities. While the health and economic risks of smoking are generally recognized, the results highlight significant discrepancies between available scientific knowledge and the views of these political leaders. The study notably underscores a tendency to favor measures deemed ineffective by the literature, a strong echo of the tobacco industry's arguments against taxation, and a concerning reliance on tobacconists as a source of expertise, to the detriment of public health professionals.[1].

The study is based on an empirical survey conducted between March and June 2022 with 25 French parliamentarians, including 17 senators and 8 members of the National Assembly, to analyze their perceptions of tobacco control policies and the actors considered legitimate to inform public policy decisions. The authors conducted semi-structured individual interviews, exploring the assessment of the health and economic risks associated with smoking, the perceived effectiveness of various tobacco control measures, and the sources of information used by elected officials. The data collected underwent a thematic qualitative analysis, supplemented by comparative analyses, to identify the main trends, divergences, and discrepancies between these political leaders' perceptions and the scientific consensus.

This work was supported by the National Cancer Institute (INCa) and the Institute for Public Health Research through the FELITAF project (Forms and effect of lobbying from the tobacco industry and their allies in France) as part of funding from the Fund to Combat Addictions.

A comprehensive understanding, but a persistent minimization of risks

The study reveals that all the parliamentarians interviewed clearly stated the harmful effects of tobacco on health, spontaneously mentioning serious illnesses such as cancer and the risks associated with secondhand smoke, as well as the addiction linked to tobacco use. This awareness of the negative impacts is also accompanied by a relative understanding of the social and economic costs generated by smoking, particularly in terms of healthcare expenditure and social inequalities. Approximately half of the participants explicitly mentioned these dimensions during the interviews, although it should be noted that many of these parliamentarians were members of the social affairs committee responsible for health issues.

The study also highlights that this knowledge is not always uniformly structured, with some parliamentarians expressing perceptions that contradict the scientific consensus. Nearly a third of the elected officials interviewed downplayed the extent of the risks associated with tobacco use, minimizing, for example, the impact of low daily consumption ("one cigarette a day"). This risk minimization suggests that, despite a general awareness of the negative health consequences, distorted perceptions persist among political decision-makers. Furthermore, the study still sometimes emphasizes perceptions of cigarettes and other tobacco products, such as cigars, as elements of pleasure, conviviality, or cultural dimensions.

These misconceptions and perceptions directly affect the assessment of public health policies. They can contribute to a general ambivalence in the evaluation of tobacco as a priority problem, limiting the understanding of the urgency of action and potentially contributing to the reluctance of some parliamentarians to fully support stronger anti-smoking measures or those based on robust scientific evidence.

Timid measures are being favored over strong policies recommended by scientific data.

When participants were asked to identify the policies they considered most effective in combating tobacco use, approximately half cited mass media information campaigns and education as levers for reducing smoking. These measures are perceived as socially acceptable and politically easy to promote, but the scientific literature emphasizes their limited effectiveness when not part of a coherent and coordinated policy package. For example, communication campaigns alone generally produce modest effects on smoking prevalence compared to structural levers such as price increases or stricter access restrictions.

Parliamentarians also acknowledged the benefits of tobacco tax increases, with some advocating for significant and regular hikes. However, this recognition is often not translated into political action due to the widespread arguments disseminated by tobacco companies and retailers regarding the growth of the black market. Nearly a third of MPs believed that only small tax increases were desirable to avoid negative economic consequences, while a similar proportion felt that only substantial increases could lead to a real reduction in smoking.

Other evidence-based measures, such as graphic health warnings on packaging or plain packaging, are perceived by some parliamentarians as having little or no effect on behavior. In the study, nearly a quarter of participants felt that the health images displayed on packs since 2017 had had no behavioral impact, despite evidence from international assessments showing that graphic warnings have a major preventive function for non-smokers but also help raise awareness of the risks for smokers and thus contribute to quitting intentions.

Perceptions of the measures also vary when more radical measures, such as a possible total ban on tobacco sales, are discussed. During the survey, approximately one-third of the parliamentarians interviewed opposed this type of "prohibitive measure," which they consider excessive or potentially counterproductive. These positions often differ in this respect from public opinion, which is more supportive of this type of measure. This was already the case with the bans on smoking in public places, where the public overwhelmingly supported the measure, including smokers, while parliamentarians were very hesitant about such a provision.

A persistent influence of the tobacco industry in the political debate

One of the most concerning findings of the study, according to the authors, lies in the continued strong influence of the arguments of the tobacco industry and its allies, particularly tobacconists, on the political views and reasoning of the parliamentarians interviewed. A large majority of them explicitly or implicitly adopt talking points traditionally used by the industry to oppose the most effective anti-smoking measures, especially tax increases on tobacco products. These arguments focus on the supposed risk of the illicit market expanding, the economic impact on tobacconists, and the negative effects on purchasing power, despite the abundance of scientific and institutional data showing that these claims are largely exaggerated or unfounded.

The authors observe a normalization of these arguments in public debate, which contributes to blurring the line between independent expertise and special interest economic lobbying. This situation is all the more problematic as it leads some elected officials to downplay the widely demonstrated effectiveness of tax policies, identified by international literature as the most powerful lever for reducing smoking, particularly among young people and the most socially vulnerable populations.

The study also highlights a marked imbalance in the sources of information used by parliamentarians to inform their decisions. Elected officials report consulting tobacconists more frequently than public health professionals, researchers, or health authorities. This prioritization of stakeholders contributes to strengthening the influence of economic interests directly linked to the sale of tobacco products, to the detriment of an approach based on independent scientific data and public health imperatives.

The authors finally emphasize that this dynamic runs counter to international provisions, in particular Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC), which aims to protect public health policies from interference by the tobacco industry.

These authors emphasize that this persistent influence stems not only from direct lobbying efforts, but is embedded in more diffuse and structural mechanisms, including the social legitimacy granted to certain economic actors and the limited visibility of scientific data in parliamentary debate. In this respect, the study highlights a central challenge for tobacco control policies in France: the need to strengthen the role of scientific expertise and public health stakeholders in the decision-making process, in order to limit the impact of tobacco industry influence strategies on regulatory choices.

©Generation Without Tobacco

AE